Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ALKEM LABS LTD

  • FDA Approval
  • July 16, 2024, 05:01 UTC
  • 51
  • 0 comments

FDA approve HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL

Comment Full text

APOTEX

  • FDA Approval
  • July 16, 2024, 05:01 UTC
  • 47
  • 0 comments

FDA approve DOXYCYCLINE

Comment Full text

GLAND PHARMA LTD

  • FDA Approval
  • July 16, 2024, 05:01 UTC
  • 50
  • 0 comments

FDA approve TRAVOPROST

Comment Full text

ALEMBIC PHARMS LTD

  • FDA Approval
  • July 16, 2024, 03:30 UTC
  • 52
  • 0 comments

FDA approve SELEXIPAG

Comment Full text

ZYDUS PHARMS USA INC

  • FDA Approval
  • July 16, 2024, 03:15 UTC
  • 47
  • 0 comments

FDA approve DIROXIMEL FUMARATE

Comment Full text

VIATRIS

  • FDA Approval
  • July 15, 2024, 18:33 UTC
  • 51
  • 0 comments

FDA approve GABAPENTIN

Comment Full text

VIATRIS

  • FDA Approval
  • July 15, 2024, 18:33 UTC
  • 44
  • 0 comments

FDA approve GABAPENTIN

Comment Full text

VIATRIS

  • FDA Approval
  • July 15, 2024, 18:33 UTC
  • 51
  • 0 comments

FDA approve GABAPENTIN

Comment Full text

HIKMA

  • FDA Approval
  • July 15, 2024, 18:33 UTC
  • 48
  • 0 comments

FDA approve GLYCOPYRROLATE

Comment Full text

PERRIGO R AND D

  • FDA Approval
  • July 15, 2024, 08:49 UTC
  • 40
  • 0 comments

FDA approve NICOTINE POLACRILEX

Comment Full text
  • Previous
  • 396
  • 397
  • 398
  • 399
  • 400
  • Next

Search

News categories

  • Technical Exchange News(11551)
  • Event(3588)
  • SEC News(218709)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(138666)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin